USANA Health Sciences (USNA) 10-Q 7 May 14 2014 Q1 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 29, 2014	5-May-14
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	29-Mar-14	'
Document Fiscal Period Focus	'Q1	'
Entity Central Index Key	'0000896264	'
Entity Registrant Name	'USANA HEALTH SCIENCES INC	'
Current Fiscal Year End Date	'--01-03	'
Document Fiscal Year Focus	'2014	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	13,922,660

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 29, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$142,733	$137,343
Securities held-to-maturity, net	4,428	8,642
Inventories	46,890	47,242
Prepaid expenses and other current assets	32,308	35,818
Total current assets	226,359	229,045
Property and equipment, net	58,843	59,180
Goodwill	17,933	18,243
Intangible assets, net	41,210	42,329
Deferred tax assets	5,695	5,519
Other assets	21,426	14,154
Total assets	371,466	368,470
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable	6,083	9,502
Other current liabilities	73,861	86,369
Total current liabilities	79,944	95,871
Deferred tax liabilities	10,577	10,866
Other long-term liabilities	1,204	1,211
Stockholders' equity	'	'
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 13,886 as of December 28, 2013 and 13,981 as of March 29, 2014	14	14
Additional paid-in capital	58,383	54,691
Retained earnings	216,560	200,023
Accumulated other comprehensive income	4,784	5,794
Total stockholders' equity	279,741	260,522
Total liabilities and stockholder's equity	$371,466	$368,470

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 29, 2014	Dec. 28, 2013
In Thousands, except Per Share data, unless otherwise specified
Condensed Consolidated Balance Sheets [Abstract]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	50,000	50,000
Common stock, shares issued	13,981	13,886
Common stock, shares outstanding	13,981	13,886

Condensed_Consolidated_Stateme

Condensed Consolidated Statements Of Comprehensive Income (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Condensed Consolidated Statements Of Comprehensive Income [Abstract]	'	'
Net sales	$182,401	$169,082
Cost of sales	33,828	30,261
Gross profit	148,573	138,821
Operating expenses:	'	'
Associate incentives	78,874	69,855
Selling, general and administrative	44,577	42,404
Total operating expenses	123,451	112,259
Earnings from operations	25,122	26,562
Other income (expense):	'	'
Interest income	212	78
Interest expense	-6	'
Other, net	-81	-104
Other income (expense), net	125	-26
Earnings before income taxes	25,247	26,536
Income taxes	8,710	8,757
Net earnings	16,537	17,779
Earnings per common share	'	'
Basic	$1.19	$1.30
Diluted	$1.15	$1.28
Weighted average common shares outstanding	'	'
Basic	13,919	13,643
Diluted	14,395	13,903
Comprehensive income:	'	'
Net earnings	16,537	17,779
Other comprehensive income (loss), net of tax:	'	'
Foreign currency translation adjustment	652	-66
Tax benefit (expense) related to foreign currency translation adjustment	-1,662	31
Other comprehensive income (loss), net of tax	-1,010	-35
Comprehensive income	$15,527	$17,744

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement Of Stockholders' Equity (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
In Thousands
Balance, value at Dec. 28, 2013	$14	$54,691	$200,023	$5,794	$260,522
Balance, shares at Dec. 28, 2013	13,886	'	'	'	13,886
Net earnings	'	'	16,537	'	16,537
Other comprehensive income (loss), net of tax	'	'	'	-1,010	-1,010
Equity-based compensation expense	'	1,836	'	'	1,836
Common stock issued under equity award plans, including tax benefit, shares	95	'	'	'	'
Common stock issued under equity award plans, including tax benefit, value	'	1,856	'	'	1,856
Balance, value at Mar. 29, 2014	$14	$58,383	$216,560	$4,784	$279,741
Balance, shares at Mar. 29, 2014	13,981	'	'	'	13,981

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement Of Stockholders' Equity (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014
Condensed Consolidated Statement Of Stockholders' Equity [Abstract]	'
Common stock issued under equity award plans, including tax benefit (expense)	$1,856

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Cash flows from operating activities	'	'
Net earnings	$16,537	$17,779
Adjustments to reconcile net earnings to net cash provided by operating activities	'	'
Depreciation and amortization	2,211	2,303
(Gain) loss on sale of property and equipment	4	-3
Equity-based compensation expense	1,836	2,369
Excess tax benefits from equity-based payment arrangements	-1,856	-185
Deferred income taxes	-146	-819
Changes in operating assets and liabilities:	'	'
Inventories	45	-6,522
Prepaid expenses and other assets	-3,339	6,136
Accounts payable	-3,704	1,097
Other liabilities	-9,119	-1,850
Net cash provided by operating activities	2,469	20,305
Cash flows from investing activities	'	'
Additions to notes receivable	-1,429	-1,142
Purchases of investment securities held-to-maturity	-1,488	'
Maturities of investment securities	5,701	'
Proceeds from sale of property and equipment	6	3
Purchases of property and equipment	-979	-872
Net cash provided by (used in) investing activities	1,811	-2,011
Cash flows from financing activities	'	'
Excess tax benefits from equity-based payment arrangements	1,856	185
Repurchase of common stock	'	-18,085
Net cash provided by (used in) financing activities	1,856	-17,900
Effect of exchange rate changes on cash and cash equivalents	-746	-186
Net increase in cash and cash equivalents	5,390	208
Cash and cash equivalents, beginning of period	137,343	70,839
Cash and cash equivalents, end of period	142,733	71,047
Supplemental disclosures of cash flow information	'	'
Interest	6	'
Income taxes	$787	$1,101

Organization_Consolidation_And

Organization, Consolidation, And Basis Of Presentation	3 Months Ended
	Mar. 30, 2013
Organization, Consolidation, And Basis Of Presentation [Abstract]	'
Organization, Consolidation, And Basis Of Presentation	'
	NOTE A – ORGANIZATION, CONSOLIDATION, AND BASIS OF PRESENTATION
	USANA Health Sciences, Inc. develops and manufactures high-quality nutritional and personal care products that are sold internationally through a global network marketing system, which is a form of direct selling. The Consolidated Financial Statements include the accounts and operations of USANA Health Sciences, Inc. and its wholly-owned subsidiaries (collectively, the “Company” or “USANA”) in two geographic regions: Americas and Europe and Asia Pacific, which is further divided into three sub-regions; Southeast Asia Pacific, Greater China, and North Asia. Americas and Europe includes the United States, Canada, Mexico, Colombia, the United Kingdom, France, Belgium, and the Netherlands.  Southeast Asia Pacific includes Australia, New Zealand, Singapore, Malaysia, the Philippines, and Thailand; Greater China includes Hong Kong, Taiwan and China; and North Asia includes Japan and South Korea. All significant intercompany accounts and transactions have been eliminated in this consolidation.
	The condensed balance sheet as of December 28, 2013, derived from audited financial statements, and the unaudited interim consolidated financial information of the Company have been prepared in accordance with Article 10 of Regulation S-X promulgated by the Securities and Exchange Commission. Certain information and footnote disclosures that are normally included in financial statements that have been prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the accompanying interim consolidated financial information contains all adjustments, consisting of normal recurring adjustments that are necessary to state fairly the Company’s financial position as of March 29, 2014 and results of operations for the three months ended March 30, 2013 and March 29, 2014. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto that are included in the Company’s Annual Report on Form 10-K for the year ended December 28, 2013.  The results of operations for the three months ended March 29, 2014, may not be indicative of the results that may be expected for the fiscal year 2014 ending January 3, 2015.

Fair_Value_Measures

Fair Value Measures	3 Months Ended
	Mar. 29, 2014
Fair Value Measures [Abstract]	'
Fair Value Measures	'
	NOTE B – FAIR VALUE MEASURES
	The Company measures at fair value certain of its financial and non-financial assets and liabilities by using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, essentially an exit price, based on the highest and best use of the asset or liability. The levels of the fair value hierarchy are:
		·		Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
		·		Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.
		·		Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.
	As of December 28, 2013 and March 29, 2014, the following financial assets and liabilities were measured at fair value on a recurring basis using the type of inputs shown:
					Fair Value Measurements Using:
			28-Dec-13		Level 1 Inputs	Level 2 Inputs	Level 3 Inputs
	Money market funds included in cash equivalents		$                    9,249		$                9,249	$                       -	$                       -
	Term deposits included in cash equivalents		348		-	348	-
					Fair Value Measurements Using:
			29-Mar-14		Level 1 Inputs	Level 2 Inputs	Level 3 Inputs
	Money market funds included in cash equivalents		$                  14,603		$              14,603	$                       -	$                       -
	Term deposits included in cash equivalents		1,440		-	1,440	-
	NOTE B – FAIR VALUE MEASURES - CONTINUED
	There were no transfers of financial assets or liabilities between Level 1 and Level 2 inputs for the periods indicated.
	The majority of the Company's non-financial assets, which include goodwill, intangible assets, and property and equipment, are not required to be carried at fair value on a recurring basis. However, if certain triggering events occur (or tested at least annually for goodwill and indefinite-lived intangibles) such that a non-financial asset is required to be evaluated for impairment, an impairment is recorded to reduce the carrying value to the fair value, if the carrying value exceeds the fair value. At December 28, 2013 and March 29, 2014, there were no non-financial assets measured at fair value on a non-recurring basis.
	At December 28, 2013 and March 29, 2014, the Company's financial instruments include cash equivalents, restricted cash, securities held-to-maturity, and notes receivable. The recorded values of cash equivalents and restricted cash approximate their fair values, based on their short-term nature. The carrying value of the notes receivable approximate fair value because the variable interest rates in the notes reflect current market rates.  Securities held-to-maturity consist of certificates of deposits. The fair value of a certificate of deposit is determined based on the pervasive interest rates in the market, which is considered to be a Level 2 input. The carrying values of these certificates of deposit approximate their fair values due to their short-term maturities.

Investments

Investments	3 Months Ended
	Mar. 29, 2014
Investments [Abstract]	'
Investments	'
	NOTE C – INVESTMENTS
	The carrying amount, gross unrealized holding gains, gross unrealized holding losses, and fair value of held-to-maturity securities by major security type and class of security were as follows:
		As of December 28, 2013
		Amortized Cost	Unrecognized Holding Gains	Unrecognized Holding Losses	Estimated Fair Value
	Certificates of Deposit	$                    8,642	$                           -	$                           -	$                    8,642
	Total Held-to-Maturity Securities	$                    8,642	$                           -	$                           -	$                    8,642
		As of  March 29, 2014
		Amortized Cost	Unrecognized Holding Gains	Unrecognized Holding Losses	Estimated Fair Value
	Certificates of Deposit	$                    4,428	$                           -	$                           -	$                    4,428
	Total Held-to-Maturity Securities	$                    4,428	$                           -	$                           -	$                    4,428

Inventories

Inventories	3 Months Ended
	Mar. 30, 2013
Inventories [Abstract]	'
Inventories	'
	NOTE D – INVENTORIES
	Inventories consist of the following:
		December 28,	March 29,
		2013	2014
	Raw materials	$             13,824	$             12,975
	Work in progress	8,147	8,585
	Finished goods	25,271	25,330
		$             47,242	$             46,890

Other_Assets

Other Assets	3 Months Ended
	Mar. 29, 2014
Other Assets [Abstract]	'
Other Assets	'
	NOTE E – OTHER ASSETS
	The Company has extended non-revolving credit to its supplier of nutrition bars of up to $7,000 to allow this supplier to acquire the necessary equipment to manufacture the USANA nutrition bars.  Notes receivable are valued at their unpaid principal balance plus any accrued but unpaid interest, which approximates fair value.  Interest accrues at an annual interest rate of LIBOR plus 400 basis points. The note has a maturity date of February 1, 2024 and will be repaid by a combination of cash payments and credits for the manufacture of USANA’s nutrition bars.  There is no prepayment penalty.  Notes receivable from this supplier as December 28, 2013, and March 29, 2014 were $4,942 and $6,421, respectively.
	The Company is building a state-of-the-art manufacturing and production facility in China, which is expected to become operational during the latter-half of 2015.  As part of this project, land-use rights totaling $7,158 have been purchased and will be amortized over 50 years.  Land-use rights are classified in “Other assets” line item in the Company’s consolidated balance sheets.

Contingencies

Contingencies	3 Months Ended
	Mar. 29, 2014
Contingencies [Abstract]	'
Contingencies	'
	NOTE F – CONTINGENCIES
	The Company is involved in various lawsuits, claims and other legal matters from time to time that arise in the ordinary course of conducting business, including matters involving our products, intellectual property, supplier relationships, distributors, competitor relationships, employees and other matters. While complete assurance cannot be given to the outcome of these proceedings, management does not currently believe that any of these matters, individually or in the aggregate, will have a material adverse effect on our financial condition, liquidity or results of operations.
	The Company has previously disclosed that the Securities and Exchange Commission is conducting a formal investigation, which involve possible issues regarding trading in the Company’s stock during late 2012 by certain of the Company’s directors, including the Chairman.  In the opinion of management, based upon advice of counsel, the likelihood of an adverse outcome against the Company in this matter is remote.  As such, management believes that the ultimate outcome of the SEC investigation will not have a material impact on the Company’s financial position or results of operations.

EquityBased_Compensation

Equity-Based Compensation	3 Months Ended
	Mar. 29, 2014
Equity-Based Compensation [Abstract]	'
Equity-Based Compensation	'
	NOTE  G — EQUITY BASED COMPENSATION
	The Company utilizes a share-based compensation plan, which is more fully described in Note K to the Consolidated Financial Statements in Form 10-K for the year ended December 28, 2013.
	Equity-based compensation expense for the three months ended March 30, 2013 and March 29, 2014, was $2,396, and $1,836 respectively.  The related tax benefit for these periods was $812, and $617, respectively.
	The following table shows the remaining unrecognized compensation expense on a pre-tax basis for all types of unvested equity awards outstanding as of March 29, 2014.  This table does not include an estimate for future grants that may be issued.
	2014	$          6,784
	2015	7,299
	2016	5,420
	2017	3,348
	2018	541
		$        23,392
	The cost above is expected to be recognized over a weighted-average
	period of 2.2 years.
	The Company uses the Black-Scholes option pricing model to estimate the fair value of its equity awards.  The weighted-average fair value of stock-settled stock appreciation rights that were granted during the three months ended March 30, 2013, and March 29, 2014, was $13.34 and $17.73, respectively.  Following is a table that includes the weighted-average assumptions that the Company used to calculate fair value of equity awards that were granted during the periods indicated.
		Three Months Ended
		March 30,	March 29,
		2013	2014
	Expected volatility (1) .	43.7%	39.9%
	Risk-free interest rate (2) .	0.6%	1.2%
	Expected life (3) .	3.97 yrs	3.54 yrs
	Expected dividend yield (4) .	0.0%	0.0%
	Weighted-average exercise price (5) .	$	$
		38.69	57.62
	(1) The Company utilizes historical volatility of the trading price of its common stock.
	(2) Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of
	the award.
	(3) Depending upon the terms of the award, expected life may be a weighted-average that includes
	historical settlement data of the Company's equity awards and a hypothetical holding
	period for outstanding awards, or it may be calculated under the simplified method.
	(4) The Company historically has not paid dividends.
	(5) Exercise price is the closing price of the Company's common stock on the date of grant.
	NOTE G – EQUITY-BASED COMPENSATION – CONTINUED
	A summary of the Company’s stock option and stock-settled stock appreciation right activity is as follows:
		Shares	Weighted-average exercise price	Weighted-average remaining contractual term	Aggregate intrinsic value*
	Outstanding at December 28, 2013	1,827	$          37.37	2.6	$        74,160
	Granted	669	57.62
	Exercised	-160	28.83
	Forfeited	-20	27.33
	Expired	-	-
	Outstanding at March 29, 2014	2,316	$          43.90	3.0	$        70,387
	Exercisable at March 29, 2014	424	$          37.96	1.9	$        15,280
	* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the
	Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.  The
	closing price of the Company's common stock at December 28, 2013, and March 29, 2014, was $77.72 and $74.02, respectively.
	The total intrinsic value of stock options and stock-settled stock appreciation rights exercised during the three months ended March 30, 2013, and March 29, 2014, was $1,150 and $6,800, respectively.  The Company currently has no deferred stock units that are considered nonvested.
	The total fair value of equity awards that vested during the three months ended March 30, 2013, and March 29, 2014, was $270 and $496, respectively.  This total fair value includes equity-based awards issued in the form of stock options and stock-settled stock appreciation rights.

Common_Stock_And_Earnings_Per_

Common Stock And Earnings Per Share	3 Months Ended
	Mar. 29, 2014
Common Stock And Earnings Per Share [Abstract]	'
Common Stock And Earnings Per Share	'
	NOTE H — COMMON STOCK AND EARNINGS PER SHARE
	Basic earnings per share are based on the weighted-average number of shares outstanding for each period. Shares that have been repurchased and retired during the periods specified below have been included in the calculation of the number of weighted-average shares that are outstanding for the calculation of basic earnings per share based on the time they were outstanding in any period. Diluted earnings per common share are based on shares that are outstanding (computed under basic EPS) and on potentially dilutive shares. Shares that are included in the diluted earnings per share calculations under the treasury stock method include equity awards that are in-the-money but have not yet been exercised.
	The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the periods indicated:
		Quarter Ended
		March 30,	March 29,
		2013	2014
	Net earnings available to common shareholders	$             17,779	$             16,537
	Basic EPS
	Shares
	Common shares outstanding entire period	13,821	13,886
	Weighted average common shares:
	Issued during period	10	33
	Canceled during period	-188	-
	Weighted average common shares outstanding during
	period	13,643	13,919
	Earnings per common share from net earnings - basic	$                1.30	$                1.19
	Diluted EPS
	Shares
	Weighted average common shares outstanding during
	period - basic	13,643	13,919
	Dilutive effect of in-the-money equity awards	260	476
	Weighted average common shares outstanding during
	period - diluted	13,903	14,395
	Earnings per common share from net earnings - diluted	$                1.28	$                1.15
	Equity awards for 1,085 and 273 shares of stock were not included in the computation of diluted EPS for the quarters ended March 30, 2013, and March 29, 2014, respectively, due to the fact that their effect would be anti-dilutive.

Segment_Information

Segment Information	3 Months Ended
	Mar. 29, 2014
Segment Information [Abstract]	'
Segment Information	'
	NOTE I – SEGMENT INFORMATION
	USANA operates as a direct selling company that develops, manufactures, and distributes high-quality nutritional and personal care products that are sold through a global network marketing system of independent distributors (“Associates”).  As such, management aggregates its operating segments into one reportable segment as management believes that the Company’s segments exhibit similar long-term financial performance and have similar economic characteristics.  Performance for a region or market is evaluated based on sales.  No single Associate accounted for 10% or more of net sales for the periods presented.  The table below summarizes the approximate percentage of total product revenue that has been contributed by the Company’s nutritional and personal care products for the periods indicated.
			Three Months Ended
			March 30,		March 29,
			2013		2014
	USANA® Nutritionals		80%		79%
	USANA Foods		12%		13%
	Sensé – beautiful science®		6%		6%
	Selected financial information for the Company is presented for two geographic regions: Americas and Europe and Asia Pacific, with three sub-regions under Asia Pacific.  Individual markets are categorized into these regions as follows:
		·		Americas and Europe – United States, Canada, Mexico, Colombia (1), the United Kingdom, France, Belgium, and the Netherlands.
		·		Asia Pacific –
		·		Southeast Asia Pacific – Australia, New Zealand, Singapore, Malaysia, the Philippines, and Thailand
		·		Greater China – Hong Kong, Taiwan and China(2)
		·		North Asia – Japan and South Korea
	(1)         The Company commenced operations in Colombia in the third quarter of 2013.
	(2)The Company’s business in China is that of BabyCare, its wholly-owned subsidiary.
	NOTE I – SEGMENT INFORMATION - CONTINUED
	Selected Financial Information
	Financial information by geographic region is presented for the periods indicated below:
			Three Months Ended
			March 30,		March 29,
			2013		2014
	Net Sales to External Customers
	Americas and Europe		$             64,152		$             63,815
	Asia Pacific
	Southeast Asia Pacific		35,309		40,448
	Greater China		62,985		70,847
	North Asia		6,636		7,291
	Asia Pacific Total		104,930		118,586
	Consolidated Total		$           169,082		$           182,401
	The following table provides further information on markets representing ten percent or more of consolidated net sales and long-lived assets, respectively:
			Three Months Ended
			March 30,		March 29,
			2013		2014
	Net sales:
	United States		$             40,238		$             37,613
	China		N/A		38,760
	Hong Kong		41,597		23,524
			As of
			December 28,		March 29,
			2013		2014
	Long-lived Assets:
	China		$             61,716		$             66,587
	United States		51,260		51,652

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 29, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	NOTE J – SUBSEQUENT EVENTS
	On April 28, 2014, the Company’s Board of Directors authorized an increase in the amount available under its share repurchase plan to a total of $200,000.  Subsequent to March 29, 2014, and through May 5, 2014, the Company repurchased and retired 58 shares of common stock for a total investment of $4,047, at an average market price of $69.51 per share.

Fair_Value_Measures_Tables

Fair Value Measures (Tables)	3 Months Ended
	Mar. 29, 2014
Fair Value Measures [Abstract]	'
Schedule Of Assets And Liabilities Measured At Fair Value	'
			Fair Value Measurements Using:
		28-Dec-13	Level 1 Inputs	Level 2 Inputs	Level 3 Inputs
	Money market funds included in cash equivalents	$                    9,249	$                9,249	$                       -	$                       -
	Term deposits included in cash equivalents	348	-	348	-
			Fair Value Measurements Using:
		29-Mar-14	Level 1 Inputs	Level 2 Inputs	Level 3 Inputs
	Money market funds included in cash equivalents	$                  14,603	$              14,603	$                       -	$                       -
	Term deposits included in cash equivalents	1,440	-	1,440	-

Investments_Tables

Investments (Tables)	3 Months Ended
	Mar. 29, 2014
Investments [Abstract]	'
Schedule Of Held-To-Maturity Securities	'
		As of December 28, 2013
		Amortized Cost	Unrecognized Holding Gains	Unrecognized Holding Losses	Estimated Fair Value
	Certificates of Deposit	$                    8,642	$                           -	$                           -	$                    8,642
	Total Held-to-Maturity Securities	$                    8,642	$                           -	$                           -	$                    8,642
		As of  March 29, 2014
		Amortized Cost	Unrecognized Holding Gains	Unrecognized Holding Losses	Estimated Fair Value
	Certificates of Deposit	$                    4,428	$                           -	$                           -	$                    4,428
	Total Held-to-Maturity Securities	$                    4,428	$                           -	$                           -	$                    4,428

Inventories_Tables

Inventories (Tables)	3 Months Ended
	Mar. 29, 2014
Inventories [Abstract]	'
Schedule Of Inventories	'
	Inventories consist of the following:
		December 28,	March 29,
		2013	2014
	Raw materials	$             13,824	$             12,975
	Work in progress	8,147	8,585
	Finished goods	25,271	25,330
		$             47,242	$             46,890

EquityBased_Compensation_Table

Equity-Based Compensation (Tables)	3 Months Ended
	Mar. 29, 2014
Equity-Based Compensation [Abstract]	'
Schedule Of Remaining Unrecognized Compensation Expense For Unvested Awards	'
	2014	$          6,784
	2015	7,299
	2016	5,420
	2017	3,348
	2018	541
		$        23,392
	The cost above is expected to be recognized over a weighted-average
	period of 2.2 years.
Schedule Of Fair Value Assumptions	'
		Three Months Ended
		March 30,	March 29,
		2013	2014
	Expected volatility (1) .	43.7%	39.9%
	Risk-free interest rate (2) .	0.6%	1.2%
	Expected life (3) .	3.97 yrs	3.54 yrs
	Expected dividend yield (4) .	0.0%	0.0%
	Weighted-average exercise price (5) .	$	$
		38.69	57.62
	(1) The Company utilizes historical volatility of the trading price of its common stock.
	(2) Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of
	the award.
	(3) Depending upon the terms of the award, expected life may be a weighted-average that includes
	historical settlement data of the Company's equity awards and a hypothetical holding
	period for outstanding awards, or it may be calculated under the simplified method.
	(4) The Company historically has not paid dividends.
	(5) Exercise price is the closing price of the Company's common stock on the date of grant.
Schedule Of Stock Option Activity	'
		Shares	Weighted-average exercise price	Weighted-average remaining contractual term	Aggregate intrinsic value*
	Outstanding at December 28, 2013	1,827	$          37.37	2.6	$        74,160
	Granted	669	57.62
	Exercised	-160	28.83
	Forfeited	-20	27.33
	Expired	-	-
	Outstanding at March 29, 2014	2,316	$          43.90	3.0	$        70,387
	Exercisable at March 29, 2014	424	$          37.96	1.9	$        15,280
	* Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the
	Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.  The
	closing price of the Company's common stock at December 28, 2013, and March 29, 2014, was $77.72 and $74.02, respectively.

Common_Stock_And_Earnings_Per_1

Common Stock And Earnings Per Share (Tables)	3 Months Ended
	Mar. 29, 2014
Common Stock And Earnings Per Share [Abstract]	'
Schedule Of Common Stock And Earnings Per Share	'
		Quarter Ended
		March 30,	March 29,
		2013	2014
	Net earnings available to common shareholders	$             17,779	$             16,537
	Basic EPS
	Shares
	Common shares outstanding entire period	13,821	13,886
	Weighted average common shares:
	Issued during period	10	33
	Canceled during period	-188	-
	Weighted average common shares outstanding during
	period	13,643	13,919
	Earnings per common share from net earnings - basic	$                1.30	$                1.19
	Diluted EPS
	Shares
	Weighted average common shares outstanding during
	period - basic	13,643	13,919
	Dilutive effect of in-the-money equity awards	260	476
	Weighted average common shares outstanding during
	period - diluted	13,903	14,395
	Earnings per common share from net earnings - diluted	$                1.28	$                1.15

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Mar. 29, 2014
Segment Information [Abstract]	'
Schedule Of Revenue Percentage By Product	'
		Three Months Ended
		March 30,	March 29,
		2013	2014
	USANA® Nutritionals	80%	79%
	USANA Foods	12%	13%
	Sensé – beautiful science®	6%	6%
Schedule Of Revenues From External Customers By Geographical Areas	'
		Three Months Ended
		March 30,	March 29,
		2013	2014
	Net Sales to External Customers
	Americas and Europe	$             64,152	$             63,815
	Asia Pacific
	Southeast Asia Pacific	35,309	40,448
	Greater China	62,985	70,847
	North Asia	6,636	7,291
	Asia Pacific Total	104,930	118,586
	Consolidated Total	$           169,082	$           182,401
Consolidated Net Sales And Long Lived Assets	'
		Three Months Ended
		March 30,	March 29,
		2013	2014
	Net sales:
	United States	$             40,238	$             37,613
	China	N/A	38,760
	Hong Kong	41,597	23,524
		As of
		December 28,	March 29,
		2013	2014
	Long-lived Assets:
	China	$             61,716	$             66,587
	United States	51,260	51,652

Organization_Consolidation_And1

Organization, Consolidation, And Basis Of Presentation (Details)	3 Months Ended
	Mar. 29, 2014
	item
Organization, Consolidation, And Basis Of Presentation [Abstract]	'
Geographic regions	2
Sub-geographical regions	3

Fair_Value_Measures_Narrative_

Fair Value Measures (Narrative) (Details) (USD $)	Mar. 29, 2014	Dec. 28, 2013
Fair Value Measures [Abstract]	'	'
Transfers of financial assets or liabilities	$0	$0
Non-financial assets	$0	$0

Fair_Value_Measures_Schedule_O

Fair Value Measures (Schedule Of Assets And Liabilities Measured At Fair Value) (Details) (USD $)	Mar. 29, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Money market funds included in cash equivalents	$14,603	$9,249
Term deposits included in cash	1,440	348
Fair Value, Inputs, Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Money market funds included in cash equivalents	14,603	9,249
Fair Value, Inputs, Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Term deposits included in cash	$1,440	$348

Investments_Details

Investments (Details) (USD $)	Mar. 29, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Schedule of Held-to-maturity Securities [Line Items]	'	'
Amortized Cost	$4,428	$8,642
Estimated Fair Value	4,428	8,642
Certificates of Deposit [Member]	'	'
Schedule of Held-to-maturity Securities [Line Items]	'	'
Amortized Cost	4,428	8,642
Estimated Fair Value	$4,428	$8,642

Inventories_Details

Inventories (Details) (USD $)	Mar. 29, 2014	Dec. 28, 2013
In Thousands, unless otherwise specified
Inventories [Abstract]	'	'
Raw materials	$12,975	$13,824
Work in progress	8,585	8,147
Finished goods	25,330	25,271
Inventories	$46,890	$47,242

Other_Assets_Details

Other Assets (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Dec. 28, 2013
Other Assets [Line Items]	'	'
Credit facility issued	$7,000	'
Receivable	6,421	4,942
Land-use rights	$7,158	'
Amortization period	'50 years	'
London Interbank Offered Rate (LIBOR) [Member]	'	'
Other Assets [Line Items]	'	'
Variable rate	4.00%	'

EquityBased_Compensation_Narra

Equity-Based Compensation (Narrative) (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Equity-Based Compensation [Abstract]	'	'
Equity-based compensation expense	$1,836	$2,396
Equity-based compensation related tax benefit	617	812
Weighted-average grant date fair value	$17.73	$13.34
Total intrinsic value of stock options and stock-settled stock appreciation rights exercised	6,800	1,150
Total fair value of equity awards vested	$496	$270

EquityBased_Compensation_Sched

Equity-Based Compensation (Schedule Of Remaining Unrecognized Compensation Expense For Unvested Awards) (Details) (USD $)	Mar. 29, 2014
In Thousands, unless otherwise specified
Equity-Based Compensation [Abstract]	'
2014	$6,784
2015	7,299
2016	5,420
2017	3,348
2018	541
Total	$23,392

EquityBased_Compensation_Sched1

Equity-Based Compensation (Schedule Of Fair Value Assumptions) (Details) (USD $)	3 Months Ended
	Mar. 29, 2014		Mar. 30, 2013
Equity-Based Compensation [Abstract]	'		'
Expected volatility	39.90%	[1]	43.70%	[1]
Risk-free interest rate	1.20%	[2]	0.60%	[2]
Expected life	'3 years 6 months 15 days	[3]	'3 years 11 months 19 days	[3]
Expected dividend yield	0.00%	[4]	0.00%	[4]
Weighted-average grant price	$57.62	[5]	$38.69	[5]
[1]	The Company utilizes historical volatility of the trading price of its common stock.
[2]	Risk-free interest rate is based on the U.S. Treasury yield curve with respect to the expected life of the award.
[3]	Depending upon the terms of the award, expected life may be a weighted-average that includes historical settlement data of the Company's equity awards and a hypothetical holding period for outstanding awards, or it may be calculated under the simplified method.
[4]	The Company historically has not paid dividends.
[5]	Exercise price is the closing price of the Company's common stock on the date of grant.Equity Based Compensation - Table 3 FootnotesAggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.B B The closing price of the Company's common stock at December 28, 2013, and March 29, 2014, was $77.72 and $74.02, respectively.

EquityBased_Compensation_Sched2

Equity-Based Compensation (Schedule Of Stock Option Activity) (Details) (USD $)	3 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 29, 2014		Dec. 28, 2013
Equity-Based Compensation [Abstract]	'		'
Shares, Outstanding	1,827		'
Shares, Granted	669		'
Shares, Exercised	-160		'
Shares, Forfeited	-20		'
Shares, Outstanding	2,316		1,827
Shares, Exercisable	424		'
Weighted-average grant price, Outstanding	$37.37		'
Weighted-average grant price, Granted	$57.62		'
Weighted-average grant price, Exercised	$28.83		'
Weighted-average grant price, Forfeited	$27.33		'
Weighted-average grant price, Outstanding	$43.90		$37.37
Weighted-average grant price, Exercisable	$37.96		'
Weighted-average remaining contractual term, Outstanding	'3 years		'2 years 7 months 6 days
Weighted-average remaining contractual term, Exercisable	'1 year 10 months 24 days		'
Aggregate intrinsic value, Outstanding	$74,160	[1]	'
Aggregate intrinsic value, Outstanding	70,387	[1]	74,160	[1]
Aggregate intrinsic value, Exercisable	$15,280	[1]	'
Closing price of common stock	$74.02		$77.72
[1]	Aggregate intrinsic value is defined as the difference between the current market value at the reporting date (the closing price of the Company's common stock on the last trading day of the period) and the exercise price of awards that were in-the- money.B B The closing price of the Company's common stock at December 28, 2013, and March 29, 2014, was $77.72 and $74.02, respectively.

Common_Stock_And_Earnings_Per_2

Common Stock And Earnings Per Share (Narrative) (Details)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Common Stock And Earnings Per Share [Abstract]	'	'
Equity awards of stock excluded in computation of diluted EPS	273	1,085

Common_Stock_And_Earnings_Per_3

Common Stock And Earnings Per Share (Schedule Of Common Stock And Earnings Per Share) (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Dec. 28, 2013	Dec. 29, 2012
Common Stock And Earnings Per Share [Abstract]	'	'	'	'
Net earnings available to common shareholders	$16,537	$17,779	'	'
Common shares outstanding entire period	13,981	'	13,886	13,821
Weighted average common shares issued during period	33	10	'	'
Weighted average common shares cancelled during period	'	-188	'	'
Weighted average common shares outstanding during period	13,919	13,643	'	'
Earnings per common share from net earnings - basic	$1.19	$1.30	'	'
Weighted average common shares outstanding during period - basic	13,919	13,643	'	'
Dilutive effect of in-the-money equity awards	476	260	'	'
Weighted average common shares outstanding during period - diluted	14,395	13,903	'	'
Earnings per common share from net earnings - diluted	$1.15	$1.28	'	'

Segment_Information_Narrative_

Segment Information (Narrative) (Details)	3 Months Ended
	Mar. 29, 2014
Segment Information [Abstract]	'
Percentage of revenue from major customers, maximum	10.00%

Segment_Information_Percentage

Segment Information (Percentage Of Total Product Revenue Contributed By Company's Nutritional And Care Products) (Details)	3 Months Ended
	Mar. 29, 2014	Mar. 30, 2013
USANA Nutritionals [Member]	'	'
Revenue from External Customer [Line Items]	'	'
Percentage of product revenue	79.00%	80.00%
USANA Foods [Member]	'	'
Revenue from External Customer [Line Items]	'	'
Percentage of product revenue	13.00%	12.00%
Sense - Beautiful Science [Member]	'	'
Revenue from External Customer [Line Items]	'	'
Percentage of product revenue	6.00%	6.00%

Segment_Information_Schedule_O

Segment Information (Schedule Of Revenues From External Customers And Assets By Geographic Region) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013
Revenues From External Customers By Geographic Area [Line Items]	'	'
Net Sales to External Customers	$182,401	$169,082
Americas And Europe [Member]	'	'
Revenues From External Customers By Geographic Area [Line Items]	'	'
Net Sales to External Customers	63,815	64,152
Southeast Asia/Pacific [Member]	'	'
Revenues From External Customers By Geographic Area [Line Items]	'	'
Net Sales to External Customers	40,448	35,309
Greater China [Member]	'	'
Revenues From External Customers By Geographic Area [Line Items]	'	'
Net Sales to External Customers	70,847	62,985
North Asia [Member]	'	'
Revenues From External Customers By Geographic Area [Line Items]	'	'
Net Sales to External Customers	7,291	6,636
Asia Pacific [Member]	'	'
Revenues From External Customers By Geographic Area [Line Items]	'	'
Net Sales to External Customers	$118,586	$104,930

Segment_Information_Consolidat

Segment Information (Consolidated Net Sales And Long Lived Assets By Percent) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 29, 2014	Mar. 30, 2013	Dec. 28, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	$182,401	$169,082	'
United States [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	37,613	40,238	'
Long-lived Assets	51,652	'	51,260
China [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	38,760	'	'
Long-lived Assets	66,587	'	61,716
Hong Kong [Member]	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'
Net sales	$23,524	$41,597	'

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended	0 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 30, 2013	5-May-14	Apr. 28, 2014
		Subsequent Event [Member]	Subsequent Event [Member]
Subsequent Event [Line Items]	'	'	'
Amount available	'	'	$200,000
Retired shares investment	$18,085	$4,047	'
Average market price	'	$69.51	'